Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,312 | 190 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $719.48 | 88 | $0 (2024) |
| ABBVIE INC. | $664.17 | 49 | $0 (2024) |
| Janssen Biotech, Inc. | $203.63 | 15 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $119.14 | 6 | $0 (2024) |
| Celgene Corporation | $97.24 | 6 | $0 (2023) |
| Amgen Inc. | $77.29 | 3 | $0 (2023) |
| PFIZER INC. | $76.69 | 4 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $71.14 | 4 | $0 (2023) |
| Ardelyx, Inc. | $65.34 | 3 | $0 (2023) |
| Gilead Sciences, Inc. | $35.91 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $439.63 | 43 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($249.51) |
| 2023 | $556.85 | 42 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($187.66) |
| 2022 | $870.55 | 68 | ABBVIE INC. ($300.78) |
| 2021 | $444.62 | 37 | AbbVie Inc. ($152.28) |
All Payment Transactions
190 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.77 | General |
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $3.92 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.67 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $0.76 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.90 | General |
| Category: Gastroenterology | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Gastroenterology | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: Gastroenterology | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.87 | General |
| Category: Gastroenterology | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: Gastroenterology | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: Gastroenterology | ||||||
| 08/27/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $23.42 | General |
| Category: GI | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: Gastroenterology | ||||||
| 07/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: Gastroenterology | ||||||
| 07/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: Gastroenterology | ||||||
| 07/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $3.88 | General |
| Category: Gastroenterology | ||||||
| 07/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.05 | General |
| Category: Gastroenterology | ||||||
| 07/30/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Immunology | ||||||
| 07/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Gastroenterology | ||||||
| 07/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: Gastroenterology | ||||||
| 06/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Gastroenterology | ||||||
| 06/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $2.08 | General |
| Category: Gastroenterology | ||||||
| 06/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 225 | 271 | $40,160 | $16,795 |
| 2022 | 5 | 211 | 267 | $39,140 | $16,422 |
| 2021 | 4 | 198 | 241 | $34,785 | $14,680 |
| 2020 | 5 | 197 | 245 | $30,730 | $11,673 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 158 | $20,040 | $8,016 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 57 | $9,690 | $4,445 | 45.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $6,720 | $2,817 | 41.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $2,800 | $1,099 | 39.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 14 | $910.00 | $418.73 | 46.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 104 | 154 | $19,250 | $8,110 | 42.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 53 | $9,010 | $3,840 | 42.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $6,240 | $2,438 | 39.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 18 | $3,600 | $1,621 | 45.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 16 | 16 | $1,040 | $412.98 | 39.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 123 | $14,900 | $5,788 | 38.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 55 | 62 | $10,295 | $4,797 | 46.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 34 | 34 | $8,160 | $3,550 | 43.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 20 | 22 | $1,430 | $544.95 | 38.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 123 | 165 | $18,765 | $6,919 | 36.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 27 | 27 | $6,480 | $2,516 | 38.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 20 | $2,200 | $980.10 | 44.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 12 | 12 | $1,920 | $726.24 | 37.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 18 | 21 | $1,365 | $531.80 | 39.0% |
About Colleen Johnson
Colleen Johnson is a Registered Nurse healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2008. The National Provider Identifier (NPI) number assigned to this provider is 1942471164.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Colleen Johnson has received a total of $2,312 in payments from pharmaceutical and medical device companies, with $439.63 received in 2024. These payments were reported across 190 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,312).
As a Medicare-enrolled provider, Johnson has provided services to 831 Medicare beneficiaries, totaling 1,024 services with total Medicare billing of $59,569. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Rochester, NY
- Active Since 03/14/2008
- Last Updated 03/21/2013
- Taxonomy Code 163W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942471164
Products in Payments
- XIFAXAN (Drug) $719.48
- HUMIRA (Biological) $242.75
- SKYRIZI (Biological) $210.45
- STELARA (Biological) $194.89
- Linzess (Drug) $119.14
- ZEPOSIA (Drug) $80.59
- XELJANZ (Drug) $76.69
- RINVOQ (Biological) $70.44
- VIBERZI (Drug) $67.57
- IBSRELA (Drug) $65.34
- LINZESS (Drug) $64.72
- AMJEVITA (Biological) $57.49
- ENTYVIO (Biological) $54.90
- DIFICID (Drug) $29.61
- DUPIXENT (Biological) $29.50
- OCALIVA (Drug) $27.07
- INJECTAFER (Drug) $24.99
- SUTAB (Drug) $21.62
- AVSOLA (Biological) $19.80
- MONOFERRIC (Drug) $19.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Rochester
Mrs. Amy Hayes, Np, NP
Registered Nurse — Payments: $9,870
Ms. Pamela Cooper, Lpn, LPN
Registered Nurse — Payments: $3,147
Rickell Gordon, Nurse Practitioner, NURSE PRACTITIONER
Registered Nurse — Payments: $2,545
Mrs. Gita Zhulovchinova, Fnp-Bc, FNP-BC
Registered Nurse — Payments: $2,434
Dr. Nicole Dominach, Dnp, Aprn, Agpcnp-Bp, DNP, APRN, AGPCNP-BP
Registered Nurse — Payments: $2,370
Michelle Dugan, Np, NP
Registered Nurse — Payments: $2,160